Call For Science SOLACI & SBHCI 2026 – Submit Your Work!

We invite you to submit scientific papers and challenging clinical cases for the SOLACI & SBHCI 2026 Congress, taking place from July 29 to 31 in São Paulo, Brazil.

We look forward to strong participation from young colleagues and experienced professionals across the region, with valuable presentations of abstracts and clinical cases in an environment of academic excellence.

Present your work at SOLACI & SBHCI 2026 and share your experience with thousands of specialists in a high-level academic setting, fostering exchange with international leaders.

🌎 Showcase your research, discuss new evidence, and take your career to the next level.

📅 Deadline: May 10, 2026
📍 São Paulo, Brazil | World Trade Center (WTC)

🚀 Be part of the largest interventional cardiology meeting in Latin America


 

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Watch Again: Clinical Implications of Structural Heart Interventions — TAVI and MitraClip in Daily Practice

The recording of the webinar “Structural Interventions: TAVI and MitraClip in Daily Practice” is now available on the SOLACI YouTube channel. The activity was...

06/03 | SOLACI Technicians & Nurses Webinar – Clinical Impact of Structural Interventions: TAVI and MitraClip in Current Practice

The Latin American Society of Interventional Cardiology (SOLACI), through its Technicians and Nurses Department, invites you to participate in a new scientific webinar entitled...

Open Session | Current Endovascular Treatment of Tricuspid Regurgitation

SOLACI and the Argentine College of Interventional Cardioangiologists (CACI) invite you to participate in a new Open Session of the Advanced Postgraduate Course in...

SOLACI Presented an Outstanding Scientific Session on Complex Coronary Lesions at EuroPCR 2026

The Latin American Society of Interventional Cardiology (SOLACI) had a prominent participation at EuroPCR 2026 through an institutional scientific session held on May 21...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Ticagrelor vs Clopidogrel in ACS Patients Receiving DOAC After PCI: More Bleeding Without Ischemic Benefit?

In patients with acute coronary syndrome (ACS) who require direct oral anticoagulation (DOAC) and undergo percutaneous coronary intervention (PCI), current guidelines recommend a dual...

T-TEER: Beyond Traditional Pulmonary Hypertension Thresholds

Significant tricuspid regurgitation (TR) is associated with progressive functional deterioration, heart failure (HF) hospitalizations, and increased mortality. In recent years, transcatheter tricuspid edge-to-edge repair...

Is left atrial appendage closure safe in patients with reduced ejection fraction?

Patients with heart failure with reduced ejection fraction (HFrEF) were excluded from the major randomized trials evaluating percutaneous left atrial appendage closure (LAAC), and...